20-minute fully premixed rapid test, the new product from Baorui helps with efficient influenza detection and builds a precise prevention and control network!
Introduction
At the transition from winter to spring, the flu epidemic enters a high-incidence period in many places, and the workload of medical institutions for testing has increased significantly.
How can we enhance the compatibility of complex samples, improve the efficiency of testing and shorten the testing time?
Baorui Biology provides you with the best solutions.
Baorui Biotechnology has newly launched SensiDirect RT Premix-ung (Probe qRT-PCR). With "sample direct expansion, full Premix and no need for preparation, and 20-minute rapid test" launched simultaneously, it helps to comprehensively accelerate the testing process, making complexity simple and waiting efficient.

Fully premixed · ultra-long stability
•
The premixed primers, probes and enzyme systems are integrated. They can be stored at 2-8℃ for 7 days without performance degradation. Prepare the solution once a week and use it for 7 days after each preparation.
✦
•
Open the lid and use immediately, reducing human error. Emergency detection can be activated at any time!
✦
"Rapid Amplification · 20-minute 'RNA Quick Test
✦
•
Equipped with ultrafast hot-start enzymes, RT-qPCR amplification can be completed in as fast as 20 minutes.
✦
•
It is three times faster than the conventional plan and the daily testing capacity has doubled!
✦
Sample direct expansion · Compatible with diversity
✦
•
Throat swabs, saliva, nasal swabs, etc. can be directly loaded for amplification without the need for nucleic acid extraction.
✦
•
The anti-interference formula solves the problem of suppressing complex samples, and the detection rate is comparable to that of traditional extraction methods!
✦
Precise and sensitive · Flu Attack
✦
•
Optimized design for multiple pathogens in the respiratory tract.
✦
•
High sensitivity detection as low as 10 copies/μL, zero tolerance for cross-reactions!
✦

Stability test✦
Preservation stability
Experimental conditions

Test methodMix the buffer, enzyme and primer probe to prepare the working solution, and store it at 2-8℃ for 7 days. A comparative test was conducted using the immediately prepared working solution of the same system as the control.
Test results of Tube A




Test results of Tube B




ConclusionMD2104-X can remain stable for 7 days at 2-8℃ when in the primer-containing probe state. In subsequent experiments, only the template needs to be added to achieve efficient amplification, making the use of reagents more convenient.
Stability test✦
Freeze-thaw stability
Experimental conditions

Test methodThe buffer, enzyme and primer probe were mixed to prepare the working solution and subjected to six freeze-thaw treatments. A comparative test was conducted using the immediately prepared working solution of the same system as the control.




ConclusionMD2104-X can remain stable after six freeze-thaw cycles in the state containing primer probes.
Rapid amplification test✦
Experimental conditions

Test results of Tube A




Figure 1 shows the test results of amplification performance of RNA under the normal procedure




Figure 2 shows the test results of amplification performance under the rapid RNA program

Test results of Tube B




Figure 3 shows the test results of amplification performance of RNA under the normal procedure




Figure 4 shows the test results of amplification performance under the rapid RNA program

Test results of Tube C



Figure 5 shows the test results of amplification performance of RNA under the conventional procedure



Figure 6 shows the test results of amplification performance under the rapid RNA program

ConclusionThe amplification performance of the MD2104-X system shows that the Ct value difference between the rapid amplification program and the conventional amplification program is less than 1, indicating that this system is suitable for rapid PCR amplifiers or rapid programs for rapid amplification.
Anti-inhibition test✦
Experimental conditions

Test methodDilute the quality control samples of influenza A and B viruses respectively with TE Buffer, nucleic acid release agent and the nucleic acid release agent added to the oral swab to the concentration to be tested, and then directly add the sample, with an addition volume of 10μL for every 20μL



ConclusionThe amplification effect of MD2104-X on background samples of release agents and oral swabs is basically comparable to that of pure template amplification diluted with TE Buffer, and it has a strong anti-inhibitory effect on release agents and oral swabs.

01
Emergency/Bedside testing (POCT)Quick reports, racing against time for test results.
02
Large-scale population screeningHigh efficiency and easy handling of sudden public health incidents.
03
Primary medical institutionsNo expensive extraction equipment is required, and the operation threshold has been significantly reduced.
04
Scientific research and animal disease detectionCompatible with complex samples and adaptable to various experimental designs.
Product Link✦


Product consultation
0756-8699969
Address: No. 88, Shuian 1st Road, Nanping Science and Technology Park, Xiangzhou District, Zhuhai City, Guangdong Province
Email: marketing@biori.com
Wechat official account |
Product consultation |
Join us |
Video Account |

